Humacyte received a Nasdaq notice for failing the $1 minimum bid rule, with shares closing below $1 for 30 consecutive business days ended July 30, 2026.
The company has until Jan. 27, 2027 to regain compliance by posting a closing bid of at least $1 for 10 consecutive business days.
The notice does not immediately affect trading on the Nasdaq Global Select Market under HUMA.
HUMA•
